0000904454-24-000134.txt : 20240213 0000904454-24-000134.hdr.sgml : 20240213 20240213093652 ACCESSION NUMBER: 0000904454-24-000134 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 EFFECTIVENESS DATE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Finepoint Capital LP CENTRAL INDEX KEY: 0001608126 ORGANIZATION NAME: IRS NUMBER: 462183973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16580 FILM NUMBER: 24622973 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 336-2200 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001608126 XXXXXXXX 12-31-2023 12-31-2023 false Finepoint Capital LP
500 Boylston Street 24th Floor Boston MA 02116
13F HOLDINGS REPORT 028-16580 000170668 801-79330 N
Stacy L. Vezina General Counsel 617-336-2212 Stacy L. Vezina Boston MA 02-13-2024 0 27 316969147
INFORMATION TABLE 2 infotable.xml ACADIA PHARMACEUTICALS INC COM 004225108 24097835 769653 SH SOLE 769653 0 0 AMICUS THERAPEUTICS INC COM 03152W109 21129265 1489025 SH SOLE 1489025 0 0 ARVINAS INC COM 04335A105 20773452 504700 SH SOLE 504700 0 0 ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 20627083 163772 SH SOLE 163772 0 0 CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110 71295 548000 SH SOLE 548000 0 0 COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123 22259 459906 SH SOLE 459906 0 0 CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116 53083 408333 SH SOLE 408333 0 0 CYTOKINETICS INC COM NEW 23282W605 36042049 431693 SH SOLE 431693 0 0 CALIDI BIOTHERAPEUTICS INC COM NEW 320703101 188750 125000 SH SOLE 125000 0 0 CALIDI BIOTHERAPEUTICS INC *W EXP 03/14/202 320703119 32760 655200 SH SOLE 655200 0 0 GALAPAGOS NV SPON ADR 36315X101 18644488 458659 SH SOLE 458659 0 0 HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111 20014212 331416 SH SOLE 331416 0 0 LIBERTY BROADBAND CORP COM SER C 530307305 14865631 184460 SH SOLE 184460 0 0 MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113 22050 735000 SH SOLE 735000 0 0 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104 62740 895000 SH SOLE 895000 0 0 MORPHIC HOLDING INC COM 61775R105 14349201 496856 SH SOLE 496856 0 0 PROTHENA CORP PLC SHS G72800108 12693562 349300 SH SOLE 349300 0 0 RELAY THERAPEUTICS INC COM 75943R102 14509749 1317870 SH SOLE 1317870 0 0 REVOLUTION MEDICINES INC COM 76155X100 17698428 617100 SH SOLE 617100 0 0 ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114 24621 439666 SH SOLE 439666 0 0 SAREPTA THERAPEUTICS INC COM 803607100 14016776 145357 SH SOLE 145357 0 0 SOLID BIOSCIENCES INC COM NEW 83422E204 5902081 961251 SH SOLE 961251 0 0 SPIRIT AIRLINES INC COM 848577102 27863000 1700000 SH Call SOLE 1700000 0 0 SPRINGWORKS THERAPEUTICS INC COM 85205L107 20327872 556928 SH SOLE 556928 0 0 SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111 20090 490000 SH SOLE 490000 0 0 TRAVERE THERAPEUTICS INC COM 89422G107 12903536 1435321 SH SOLE 1435321 0 0 YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117 13279 489999 SH SOLE 489999 0 0